Pulmonology · Pulmonary Aspergillosis

Aspergillus in the Lungs: Chronic vs. Invasive Disease

At a Glance

Finding Aspergillus niger in a lung sample does not always mean active infection. It may be colonization, chronic disease in damaged lungs, or rapidly serious invasive disease; symptoms, timing, immune status, scans, and tests determine the next step.

When Aspergillus niger is found in a lung sample, it is rarely an emergency for a healthy person. However, for those with underlying lung conditions or weakened immune systems, it can lead to two very different types of disease: Chronic Pulmonary Aspergillosis (CPA) and Invasive Pulmonary Aspergillosis (IPA) ^[1]^[2].

Understanding which category you fall into depends on your medical history, how long you have been feeling unwell, and what your latest imaging (like a CT scan) shows.

Presence vs. Problem: The Role of Colonization

The most common scenario when A. niger appears in a cough sample (sputum) is colonization. This means the fungus is living in your airways or in an old lung cavity without actually attacking your body ^[3]^[4].

Many patients with Aspergillus in their respiratory samples are found to be “colonized” and do not require aggressive treatment ^[3]. Doctors usually only treat the fungus if you have symptoms (like a persistent cough or weight loss) and matching changes on a CT scan ^[1]^[4].

Sometimes, the fungus grows into a solid mass called a “fungal ball” (aspergilloma) inside a pre-existing lung cavity. A simple, stable aspergilloma may be asymptomatic and observed without treatment ^[1].

Chronic Pulmonary Aspergillosis (CPA)

When an aspergilloma causes symptoms or progressive damage, it is part of CPA. CPA typically develops over three months or longer ^[1]^[5]. It usually affects people who have “structural” lung damage—areas where the lung has been scarred or hollowed out by other diseases ^[6].

Who is at risk?: People with a history of tuberculosis (TB), COPD, sarcoidosis, or prior lung surgery ^[6]^[3].
What it looks like: The fungus can grow into a mass called an aspergilloma inside a cavity ^[1].
Symptoms: These include a chronic cough, fatigue, unintentional weight loss, and occasionally coughing up blood (hemoptysis) ^[7]^[4].

Invasive Pulmonary Aspergillosis (IPA)

IPA is a much more serious infection. The fungus doesn’t just sit in a cavity; it actively invades the lung tissue and blood vessels ^[7]^[8].

Who is at risk?: This occurs in patients with severely weakened immune systems (such as neutropenia or organ transplant), ICU patients with influenza or COVID-19, severe COPD, or those on prolonged/high-dose corticosteroids ^[9]^[10].
Symptoms: These appear quickly and include high fever (though fever may be absent), chest pain, and rapidly worsening shortness of breath ^[11]^[12].

When to Seek Urgent Care for Lung Symptoms

Call Emergency Services immediately if you experience:

More than a scant amount of blood, ongoing bleeding, clots, breathlessness, faintness, rapid heartbeat, or an inability to protect your airway ^[7].

Contact your clinician the same day if you experience:

A new streak of blood, new or worsening breathlessness, chest pain, confusion, or low oxygen.

Why A. niger is Unique in the Lungs

While A. fumigatus is the most common species found in lung infections, A. niger (and its “cryptic” relatives) can still cause significant disease ^[13]^[14].

A potential challenge with A. niger is that most clinical Aspergillus IgG tests use a validated assay that has variable cross-reactivity ^[15]. A negative result does not by itself exclude CPA, and species-specific assays are not uniformly available or required.

Feature	Chronic (CPA)	Invasive (IPA)
Primary Risk	Existing lung scars (TB, COPD)	Weak immune system, ICU, prolonged steroids
Development	Months to Years	Days to Weeks
Main Symptoms	Chronic cough, weight loss	Fever, chest pain, new breathlessness
CT Findings	Cavities, fungal balls	Rapidly growing spots or “halos”
Urgency	Careful monitoring/Long-term meds	Emergency hospital treatment

Common questions in this guide

What does finding Aspergillus niger in a sputum sample mean?

It does not always mean that Aspergillus is actively infecting the lungs. The fungus may simply be colonizing the airways or an old cavity, but symptoms and matching changes on a CT scan can suggest active disease.

How do doctors distinguish chronic pulmonary aspergillosis from invasive disease?

Chronic pulmonary aspergillosis usually develops over three months or longer in people with damaged or scarred lungs and may cause a long-lasting cough, fatigue, weight loss, or coughing up blood. Invasive pulmonary aspergillosis can worsen over days to weeks, invade lung tissue and blood vessels, and is more likely in people with severe immune suppression or critical illness.

Does Aspergillus niger in the lungs always need treatment?

No. Colonization and a stable, symptom-free aspergilloma may be monitored rather than treated aggressively. Treatment is more likely when symptoms, progressive lung damage, or concerning scan findings indicate active disease, while invasive disease requires urgent hospital care.

When should I seek emergency help for Aspergillus-related lung symptoms?

Call emergency services for more than a small amount of blood, ongoing bleeding, blood clots, severe breathlessness, faintness, a rapid heartbeat, or inability to protect your airway. A new streak of blood, worsening breathlessness, chest pain, confusion, or low oxygen should prompt same-day contact with a clinician.

Can a negative Aspergillus IgG test rule out chronic pulmonary aspergillosis?

No. Standard Aspergillus IgG tests can have variable cross-reactivity when Aspergillus niger is involved, so a negative result alone does not exclude chronic pulmonary aspergillosis. Clinicians interpret the result alongside symptoms, CT findings, medical history, and other tests.

Who is most at risk for invasive pulmonary aspergillosis?

Risk is higher in people with severely weakened immune systems, neutropenia, an organ transplant, severe COPD, or prolonged or high-dose corticosteroid use. It can also occur in critically ill patients with influenza or COVID-19.

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Aspergillus niger infection.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Curated prompts to bring to your next appointment.

1.Given my history of COPD or prior lung issues, do you suspect this is chronic colonization or an active infection?
2.Does my recent CT scan show any new cavities, nodules, or a 'fungal ball' that would point toward CPA?
3.If this is an infection, is it progressing rapidly (like IPA) or slowly (like CPA), and how does that change my immediate treatment?
4.Should we perform a bronchoscopy to get a cleaner sample and check for 'galactomannan' or tissue invasion?
5.Since A. niger was found, should we test for A. niger-specific IgG antibodies rather than just the standard A. fumigatus test?
6.What are the risks of 'hemoptysis' (coughing up blood) in my case, and what is the emergency plan if that happens?

References (15)

1
Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
Denning DW, Cadranel J, Beigelman-Aubry C, et al.
The European respiratory journal 2016; (47(1)):45-68 doi:10.1183/13993003.00583-2015.
PMID: 26699723
2
Pulmonary Aspergillosis: What the Generalist Needs to Know.
El-Baba F, Gao Y, Soubani AO
The American journal of medicine 2020; (133(6)):668-674 doi:10.1016/j.amjmed.2020.02.025.
PMID: 32240631
3
Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization.
Ohara S, Tazawa Y, Tanai C, et al.
Respiratory investigation 2016; (54(2)):92-7.
PMID: 26879478
4
A Silent Threat in Post-Tuberculosis Patients: Chronic Pulmonary Aspergillosis Survey in Multiple Regions of Indonesia (I-CHROME Study).
Rozaliyani A, Setianingrum F, Isbaniah F, et al.
Journal of fungi (Basel, Switzerland) 2025; (11(5)) doi:10.3390/jof11050329.
PMID: 40422663
5
Chronic Pulmonary Aspergillosis: Notes for a Clinician in a Resource-Limited Setting Where There Is No Mycologist.
Bongomin F, Asio LG, Baluku JB, et al.
Journal of fungi (Basel, Switzerland) 2020; (6(2)) doi:10.3390/jof6020075.
PMID: 32498415
6
The emergence of Aspergillus species in chronic respiratory disease.
Yii AC, Koh MS, Lapperre TS, et al.
Frontiers in bioscience (Scholar edition) 2017; (9(1)):127-138 doi:10.2741/s477.
PMID: 27814579
7
The Conundrum of Computed Tomography Findings in Chronic Pulmonary Aspergillosis: Insights From 103 Cases.
Garg M, Bhatia H, Sehgal I, et al.
Journal of thoracic imaging 2025; (40(5)) doi:10.1097/RTI.0000000000000828.
PMID: 40143441
8
Unusual case of chronic cavitary pulmonary aspergillosis presenting as spontaneous pneumothorax in an immunocompromised man.
S Kumar S, Ray A, Vikram NK, Vyas S
BMJ case reports 2021; (14(8)) doi:10.1136/bcr-2021-241655.
PMID: 34340987
9
Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment.
Russo A, Tiseo G, Falcone M, Menichetti F
Infectious diseases and therapy 2020; (9(3)):511-524 doi:10.1007/s40121-020-00315-4.
PMID: 32638227
10
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al.
The Lancet. Respiratory medicine 2018; (6(10)):782-792 doi:10.1016/S2213-2600(18)30274-1.
PMID: 30076119
11
Pulmonary aspergillosis: diagnosis and treatment.
Lamoth F, Calandra T
European respiratory review : an official journal of the European Respiratory Society 2022; (31(166)) doi:10.1183/16000617.0114-2022.
PMID: 36450372
12
Role of COPD in a case of fatal Aspergillus niger tracheobronchitis.
Ashby T, Green K, Burcher KM, Louis M
BMJ case reports 2023; (16(3)) doi:10.1136/bcr-2022-251807.
PMID: 36948520
13
Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study.
Aguilar-Company J, Martín MT, Goterris-Bonet L, et al.
Mycoses 2019; (62(9)):765-772 doi:10.1111/myc.12950.
PMID: 31162731
14
Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.
Cho SY, Lee DG, Choi JK, et al.
Medicine 2017; (96(49)):e8841 doi:10.1097/MD.0000000000008841.
PMID: 29245249
15
Improving Diagnostic Sensitivity of Chronic Pulmonary Aspergillosis Using Species-Specific IgG.
Sehgal IS, Agarwal R, Muthu V, et al.
Mycoses 2025; (68(9)):e70107 doi:10.1111/myc.70107.
PMID: 40899055

This page explains how Aspergillus niger in a lung sample may represent colonization, chronic pulmonary aspergillosis, or invasive disease for informational purposes only and does not replace professional medical advice. A clinician should interpret your symptoms, scans, and test results and advise when urgent care is needed.

Guide Contents